← Open Payments lookup

JAY VEGA: Open Payments

NPI 1457395659 · CUT OFF, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$649 in 38 payments from 14 companies in 2025. Trend: 2023 $518 · 2024 $606 · 2025 $649

Food & beverage: $649
CompanyPaymentsAmount
ABBVIE INC.14$174
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$98
Vanda Pharmaceuticals Inc.4$97
AstraZeneca Pharmaceuticals LP3$50
Axsome Therapeutics, Inc.2$43
Astellas Pharma US Inc2$34
Novo Nordisk Inc2$31
Supernus Pharmaceuticals, Inc.1$20
Phathom Pharmaceuticals, Inc.1$19
Bayer Healthcare Pharmaceuticals Inc.1$18

Products named: CAPLYTA, FANAPT, VRAYLAR, QULIPTA, Auvelity, Veozah, UBRELVY, Qelbree.

Industry payments across LA — which companies pay providers there.